Accessing compounded tirzepatide online through Losing Weight RX gives eligible patients a licensed clinician evaluation and 503A pharmacy fulfillment at $99/mo flat with $0 membership fees. Pre-Black Friday Special: Dual GLP-1/GIP therapy now $99/mo flat across all doses (was $399/mo). Free 1-2 day delivery & free Zofran® included!

From assessment to delivery in as few as 4 days. No office visits required.
Answer a 5-minute health questionnaire covering your medical history, current medications, and weight loss goals.
A board-certified U.S. physician evaluates your profile and prescribes tirzepatide if clinically appropriate.
Your prescription is compounded by a licensed 503A pharmacy and cold-shipped express in 3–5 business days.
Dual-action GLP-1/GIP agonist with superior clinical outcomes.
Tirzepatide activates both GLP-1 and GIP receptors for enhanced appetite suppression and metabolic improvement. Clinical trials show up to 22.5% body weight reduction.
Medication, provider consultation, free Zofran®, and free 1-2 day cold-chain shipping included on Pre-Black Friday 75% OFF promo. Flat rate locked across every dose!
Licensed U.S. physicians prescribe if clinically appropriate. Ongoing clinical support included throughout your treatment journey.
Custom-compounded by licensed 503A pharmacies. Temperature-controlled cold-chain shipping to your door in 3–5 business days.
First-in-class dual agonist backed by the SURMOUNT clinical trial program.
Tirzepatide is the first dual GLP-1/GIP receptor agonist — a medication that targets two incretin hormone pathways simultaneously for enhanced metabolic benefits.
No hidden fees. No surprise charges. Everything included.
Compounded tirzepatide contains the same active ingredient as brand-name Mounjaro® and Zepbound®, custom-prepared by a licensed 503A compounding pharmacy for individual patient use when clinically appropriate. Compounded medications are not FDA-approved products.
Tirzepatide activates both GLP-1 and GIP receptors (dual agonist), while semaglutide only activates GLP-1. Clinical trials show tirzepatide produces greater weight loss on average (22.5% vs. 15–17%). However, individual responses vary and your provider can help determine which is right for you.
The SURMOUNT-1 trial showed participants losing up to 22.5% of body weight over 72 weeks — for example, a 250 lb person could lose over 56 lbs. 91% of participants achieved at least 5% weight loss. Individual results vary.
No. Our $99/mo pricing is designed for cash-pay patients. Compare to Zepbound at $299–$449/mo through the manufacturer or Mounjaro at $1,000+/mo without insurance. No prior authorization needed. HSA/FSA accepted.
Similar to semaglutide: nausea, vomiting, diarrhea, and constipation. These typically improve as your body adjusts over the first few weeks. Your provider will guide gradual dose titration to minimize side effects.
Both are highly effective GLP-1 medications. Tirzepatide may produce greater weight loss due to its dual receptor activity but comes at a higher price point ($99 vs. $49/mo). Your provider will review your health profile and goals to recommend the best option.

Complete your online medical intake now. If clinically appropriate, your compounded tirzepatide will be shipped express to your door. $99/mo, all-inclusive.
Begin Assessment →Independent pharmacoeconomic comparison of flat-rate Section 503A compounded protocols (pure base API only, $0 monthly membership fee) versus brand-name cash list prices, paired with standard U-100 insulin syringe unit calibration.
Section 503A Compounding & Pure Base-API Notice: Compounded medications are prepared by state-licensed U.S. Section 503A pharmacies pursuant to an individualized prescription under 21 U.S.C. § 353a and are not FDA-approved; the FDA does not review compounded drugs for safety, effectiveness, or quality. Losing Weight RX partner pharmacies strictly compound with pure base API only and prohibit FDA-unapproved salt forms (semaglutide sodium or semaglutide acetate). Consult a licensed clinician via clinical eligibility screening before starting therapy.
The clinical efficacy, dosing, safety, and regulatory information in Compounded Tirzepatide Online: $99/mo Flat-Rate Care is supported by the following peer-reviewed studies and authoritative .gov / .edu sources: